Delivery Order SPE2DB22D3004-SPE2DB25FRD31
Award Date 6/20/25
Potential Completion Date 6/23/25
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4,568,984,056 units of UBRELVY 100 mg tablets in unit dose packages of 16 tablets, valued at $59,129.24. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 5, 2025, and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication, and this delivery order represents fulfillment...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,270.92 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose packaging) with an ultimate completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (100-count unit dose packages) on October 29, 2025, with a ceiling value of $1,146.60 and completion date of October 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication, representing one of...
- The Defense Logistics Agency awarded a delivery order valued at $42,518.73 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16-count unit dose packaging) on August 14, 2025, with completion targeted for August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication, reflecting the broad...
- The Defense Logistics Agency awarded a delivery order valued at $1,860.47 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose packets) on August 4, 2025, with completion scheduled for August 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. UBRELVY is a migraine treatment medication, and the award reflects the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.96 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10 unit dose packages) on August 14, 2025, with an ultimate completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December...
- The Defense Logistics Agency awarded a $4,831.85 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging (10 tablets per dose). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $6,090.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose packages) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication, reflecting the company's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a delivery order valued at $30,259.15 to AmerisourceBergen Drug Corp for UBRELVY 100 MG tablets (16-count units) on October 30, 2025, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. UBRELVY is a prescription medication used for acute migraine treatment, reflecting the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,179.09 for UBRELVY 100 mg tablets (10-unit dose packaging) on October 20, 2025, with completion scheduled for October 21, 2025. This is a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...